Find a Doctor

Fred K. Chen

University Of Western Australia


Fred Chen is in Nedlands, Australia. They have been an author on 143 peer reviewed articles and participated in 1 clinical trial in the past 15 years.


Nedlands, WA, AU

Latest Research

Latest Advance
  • Condition: Malignant Pleural Mesothelioma (MPM)
  • Journal: Lung cancer (Amsterdam, Netherlands)
  • Treatment Used: Single Oral FGF Inhibitor, AZD4547 as Second or Third Line Therapy
  • Number of Patients: 55
  • Published —
This study assessed the effectiveness of AZD4547, an oral tyrosine multi-kinase FGFR 1-3 inhibitor, as a second or third-line treatment in patients with malignant pleural mesothelioma (MPM) who relapse after treatment with first-line chemotherapy.
Latest Advance
  • Condition: Central Retinal Vein Occlusion
  • Journal: JAMA ophthalmology
  • Treatment Used: Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab ALone
  • Number of Patients: 58
  • Published —
The study compared ranibizumab plus laser-induced chorioretinal anastomosis vs ranibizumab alone in treating central retinal vein occlusion.
Latest Advance
  • Condition: Age-Related Macular Degeneration (AMD)
  • Journal: Ophthalmology
  • Treatment Used: Sub-Threshold Nanosecond Laser (SNL) Intervention
  • Number of Patients: 292
  • Published —
This study evaluated the safety of sub-threshold nanosecond laser (SNL) treatment in intermediate age-related macular degeneration (iAMD) and its effectiveness for slowing progression to late age-related macular degeneration.

Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Drug
  • Participants: 600
  • Start Date: October 5, 2017
Single Site, Randomized, Double Blind, Placebo-Controlled Study to Assess the Long-Term Safety of Tafenoquine


Nedlands, WA, AU


Contact them to find out if they accept your insurance plan.